Monopar Therapeutics
MNPR
#8837
Rank
NZ$0.14 B
Marketcap
$28.26
Share price
7.31%
Change (1 day)
799.35%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of June 2024 : NZ$11.91 Million

According to Monopar Therapeutics's latest financial reports the company has NZ$11.91 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$20.66 M-30.48%
2021-12-31NZ$29.72 M28.15%
2020-12-31NZ$23.19 M18.23%
2019-12-31NZ$19.62 M90.94%
2018-12-31NZ$10.27 M-18.75%
2017-12-31NZ$12.64 M322.67%
2016-12-31NZ$2.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.47 B 3,923.25%๐Ÿ‡บ๐Ÿ‡ธ USA